← All stocks

Metagenomi Therapeutics, Inc.

MGX Net buying

CIK 0001785279 #4736 in the set updated 17 Sep 2026

Bought (120 mo)

$13.05M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$112.48K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$112.48K

26 of 26 sales

Net

+$12.94M

+$12.94M against sales at will

By person

12 insiders · 30 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Novo Holdings A/S entity

10% owner

$13.03M (2)

—

+$13.03M

1,739,175

$2.05M

—

Wapnick Pamela

Chief Financial Officer

—

$41.23K (9)

−$41.23K

206,580

$243.76K

—

Thomas Brian C.

Director

—

$30.55K (3)

−$30.55K

2,510,960

$2.96M

+5.6%

Irish Jian

See Remarks

—

$26.83K (6)

−$26.83K

668,106

$788.37K

+27.1%

Reid Laurence

Director

$23.40K (2)

—

+$23.40K

20,000

$23.60K

—

Noonberg Sarah B.

Chief Medical Officer

—

$9.17K (1)

−$9.17K

109,135

$128.78K

+156.1%

Wein Matthew

See Remarks

—

$4.72K (7)

−$4.72K

126,133

$148.84K

+2,878%

BAYER HEALTHCARE LLC entity

10% owner

—

4,050,997

$4.78M

—

Bernales Sebastian

Director

—

2,666,290

$3.15M

+938.1%

Harnest Simon

See Remarks

—

122,664

$144.74K

+10.4%

Delaney Simren

See Remarks

—

93,892

$110.79K

+8.0%

Borges Luis

Chief Scientific Officer

—

69,316

$81.79K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 58

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 26

Transactions with no price 0

Shares from compensation/vesting 8,578,746

History held since 14 Feb 2024